New spray could bring relief to seniors with chronic dry mouth
NCT ID NCT06984848
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an enzyme-containing mouth spray (Oral7) can relieve dry mouth symptoms and improve quality of life in adults aged 60 and older. One hundred participants will receive either the active spray or a placebo for four weeks. The goal is to see if the spray increases saliva flow and reduces discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERIATRIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universiti Sains Malaysia
RECRUITINGKubang Kerian, Kelantan, 16150, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new scale unlock why people struggle to change habits?
- Can a tailored program ease the toll of injuries on older adults living alone?
- Citrus compound d-limonene put to the test against radiation-induced dry mouth
- Touch and tingle: Non-Drug therapies aim to tame chemo side effects
- Robot coach vs. classic exercises: which better prevents falls in seniors?
- Radiation's hidden toll: study tracks tooth loss in cancer survivors